CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome. - Wikidata - awgldk - TriplyDB

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

http://www.wikidata.org/entity/Q36232078

about

Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model The role of chemotherapy and operation on lymphocytes accumulation in peripheral blood obtained from patients with oral squamous cell carcinoma Altered Hepa1-6 cells by dimethyl sulfoxide (DMSO)-treatment induce anti-tumor immunity in vivo Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis.CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function.Physiologically activated mammary fibroblasts promote postpartum mammary cancer An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment.Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential.The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment.Voluntary exercise slows breast tumor establishment and reduces tumor hypoxia in ApoE-/- mice.Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay.Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response.Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas.Phyto-polyphenols as potential inhibitors of breast cancer metastasis.Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life

P2860

Q36184480-ABDFA3FD-12ED-446B-B33B-F20443E783C2 Q36274970-E847FFEF-4FF5-45D6-AB99-2C1F861C2ADA Q36962599-12F93452-6495-48FB-B071-AA5801EBC36C Q37669509-DF916CB6-187A-41B0-B007-6E00D6D1F733 Q37706688-8B64E351-51A3-42A5-96F1-F42D9ACC7C6A Q37711835-1B46FAAC-4061-4701-B583-547CD4C2F718 Q38702278-2920C58F-65BF-428F-BF13-6E8556E9F0E8 Q38948901-F5349F8F-BD56-4AC1-9028-91CD2549B3CF Q39172481-FC17568E-8D54-4AC7-9679-F5D3A03CBA7B Q39449113-A3C19423-5911-4D92-B4BF-9F4FACB05980 Q40214905-E9772F89-BCF3-45A3-9D46-ED996EBEE6B8 Q40252077-007B5A2B-122D-47E8-BA4B-611ED0711AF4 Q47122756-BFA04DD8-5E59-4F9D-9C8C-DD2844FB8500 Q48093934-10A6F03A-1510-4B90-86E6-CDFD1B09C7B0 Q52708876-DA6D9B3D-D5FB-4DBB-A7F1-96215E6F214C Q52878728-25ED054A-A12D-46EF-9745-D93D91143FD5 Q52881463-92D0BD3E-C8E6-498C-8F0A-759C33D5C15A Q55002808-0413406D-7D81-49C6-A58F-8747386EED50 Q55398260-9156CDB9-5EE3-4DA0-B566-0726EA80C878 Q55491670-C6C170B4-E23F-4A48-856A-2EB13C4702A4 Q55617875-32C415F6-7557-4B08-B215-59C13FB5FF16 Q58690952-5BA90365-0DBC-463E-9872-24ADAB9E7DBB Q58764400-314C2FA7-BD75-40F0-81EB-087776C452C1 Q58771453-93690D81-8C66-45C4-86F3-8510855E3421

P2860

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

http://www.wikidata.org/entity/Q36232078

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

@ast

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

@en

type

label

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

@ast

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

@en

prefLabel

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

@ast

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

@en

P1433

Q36232078-256D8499-DDC0-45F4-895F-604BCF68A780

P1476

Q36232078-F8E9AE25-FBA1-4F90-A74F-617774EC3635

P2093

Q36232078-1919EB0D-97A6-4FE5-B006-77A81E34A88E

Q36232078-3E38E00D-8B58-4187-9D15-4598D66F4719

Q36232078-45B1C837-3440-4A34-9966-049F66427E0A

Q36232078-4F723384-16B1-45F4-BEB1-80BA8214E57C

Q36232078-69E9DA47-1A82-4C6A-93FD-26ABC85DF0A6

Q36232078-7888CD00-CEA6-40C9-BEE6-41DF7898C98D

Q36232078-7D7BF40A-CB7C-4866-B37A-9D8E1A113406

Q36232078-B8673879-9AA0-4FE9-9110-EBD8AC9FB787

Q36232078-B926E9B2-A784-4556-AC85-52E57002B08F

Q36232078-BA799EC7-E2DC-4B6D-A15E-644D5F70E32C

P2860

Q36232078-014ACAB0-30EE-4169-9EAC-98FD34AE960C

Q36232078-0BA542C4-BC0B-44C3-8D05-6DD98E64CA65

Q36232078-0BB80D9D-AA93-4608-A5DA-5DB23B6F1D59

Q36232078-0D51B82F-881B-4017-A4E6-E2D6D784CCE0

Q36232078-1B5E0F5C-3E7C-401F-B2B0-FB7D6790A73B

Q36232078-2CB6B72F-36A7-44B7-9AE9-F8C89C738F24

Q36232078-2D20E0B0-FCE6-4929-A458-9452090A06CA

Q36232078-2D2F5138-06EC-4230-9856-5BF722BD77CD

Q36232078-3328FBCA-56AA-4158-9384-A79BA3652586

Q36232078-33905515-E5B3-4D24-98B4-1FB33A987B7C

P304

Q36232078-5B8A2D3D-80BA-427D-BEB0-FF38FDF683B8

P31

Q36232078-0D8E3C2A-5DE1-4E81-A3B4-53EDB3958B12

P356

Q36232078-8DCE45F2-F258-4B2F-ABC2-9E377A66F148

P407

Q36232078-26DE69A7-9E06-4E7A-8A8C-1257D1DCDF04

P433

Q36232078-48F30281-5780-4046-A300-E4FB5415B20A

P478

Q36232078-46BFBA26-47C6-4984-9160-2DDEE53E1936

P577

Q36232078-C020B776-AF9F-430B-859F-E5382CA7156E

P5875

Q36232078-7367E582-861C-4B22-AF5D-59A6D839434C

P698

Q36232078-190E0518-6241-4C89-91AD-D79B89133800

P932

Q36232078-E44C70C9-EA5E-4521-968C-1262DC1ECC00

P356

ONCOTARGET.3958

P1433

P1476

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

@en

P2093

Chunling Ma

http://www.w3.org/2001/XMLSchema#string

Daniel F Hoft

http://www.w3.org/2001/XMLSchema#string

Eddy C Hsueh

http://www.w3.org/2001/XMLSchema#string

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Guangyong Peng

http://www.w3.org/2001/XMLSchema#string

Jian Ye

http://www.w3.org/2001/XMLSchema#string

Mark A Varvares

http://www.w3.org/2001/XMLSchema#string

Pamela Hunborg

http://www.w3.org/2001/XMLSchema#string

Qunyuan Zhang

http://www.w3.org/2001/XMLSchema#string

Yanping Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

The role and regulation of human Th17 cells in tumor immunity

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Molecular portraits of human breast tumours

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

The three Es of cancer immunoediting

The immunobiology of cancer immunosurveillance and immunoediting

The immune contexture in human tumours: impact on clinical outcome

Imagable 4T1 model for the study of late stage breast cancer.

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

P304

17462-17478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3958

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276362483

http://www.w3.org/2001/XMLSchema#string

P698

25968569

http://www.w3.org/2001/XMLSchema#string

P932

4627321

http://www.w3.org/2001/XMLSchema#string